Lung Preservation Systems Market: By Technique, Static Cold Storage, Others), By Solution Solution, Human Biosystem Solution, Renograf, Viaspen, Lifor, Perfadex, Others), By End User, and Region Forecast 2020-2031

download arrow download arrow Download Sample
settings arrow settings arrow email us

Lung Preservation Systems Market Size, Share, Growth, Trends, and Global Industry Analysis: By Technique (Hypothermic Perfusion Preservation (HPP), Static Cold Storage (SCS), Others), By Solution (Custodiol HTK (Histidine-Tryptophan-Ketoglutarate) Solution, Human Biosystem (HBS) Solution, Renograf, Viaspen, Lifor, Perfadex, Others), By End User (Hospitals, Clinics, Others), and Region Forecast 2020-2031

checked icon checked icon arrow_drop_down
checked icon Single User License $4400 $3520
checked icon Multiple User License $6600 $5280
checked icon Corporate User License $8900 $7120

Lung Preservation Systems Market size was valued at US$ 195.0 million in 2024 and is expected to reach US$ 309.1 million by 2031, growing at a significant CAGR of 6.8% from 2025-2031. Lung preservation is the process of protecting and maintaining the donor lung from lung procurement up to the implantation in the desired recipients. Perfusion volume and pressure, temperature, oxygenation, and degree of inflation are the key factors impact the lung injury during the preservation or at the time of preservation, and lung function after the transplantation to recipients. Lung procurement is usually performed after the brain death or cardiac death of the patients.

summary download arrow Download Sample

Global Lung Preservation Systems Market Summary

Study Period

2025-2031

Base Year

2024

CAGR

6.8%

Largest Market

North-America

Fastest Growing Market

Europe

Lung Preservation Systems Market Dynamics

Increase in the number of brain death cases due to rise in number of accidents and traumatic injuries is a key factor drives the global market. Moreover, increase in the awareness about the organ donation among the people, government initiations for the organ transplantation procedures, sophisticated healthcare infrastructure in the developed countries, rise in R&D expenditure for the development of newer methods for lungs storage, and favorable reimbursement policies are anticipated to spur the global market over the forecast period.

However, high cost of procedure, dearth of skilled persons in underdeveloped regions, and limited scope at the end user level are hinder the growth of the market.

Global Lung Preservation Systems Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2025-2031

Market Size in 2024

US$ 195.0 million

Market Size in 2031

US$ 309.1 million

Market CAGR

6.8%

By Technique

  • Hypothermic Perfusion Preservation (HPP)
  • Static Cold Storage (SCS)
  • Others

By Solution

  • Custodiol HTK - (Histidine-Tryptophan-Ketoglutarate) Solution
  • Human Biosystem (HBS) Solution
  • Renograf
  • Viaspen
  • Lifor
  • Perfadex
  • Others

By End User

  • Hospitals
  • Clinics
  • Others

By Region

  • North America (U.S., Canada)
  • Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
  • Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific)
  • Latin America (Mexico, Brazil, Argentina, Columbia, Rest of Latin America)
  • Middle East & Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa)

Key Features of the Report

  • The lung preservation systems market report provides granular level information about the market size, regional market share, historic market (2020-2024), and forecast (2025-2031)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

Lung preservation systems market size was valued at US$ 195.0 million in 2024 and is expected to reach US$ 309.1 million by 2031, growing at a significant CAGR of 6.8%.

The market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.

The market key players are Franz Kohler Chemie GmbH (Germany), Organ Recovery Systems (U.S.), Waters Medical Systems LLC (U.S.), Essential Pharmaceuticals LLC (U.S.), Xvivo Perfusion AB (Sweden), BioLife Solutions, Inc. (U.S.), Preservation Solutions, Inc. (U.S.), Transmedics, Inc. (U.S.), CryoLife, Inc. (U.S.)

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1.Executive Summary
2.Global Lung Preservation Systems Market Introduction 
2.1.Global Lung Preservation Systems Market  - Taxonomy
2.2.Global Lung Preservation Systems Market  - Definitions
2.2.1.Technique
2.2.2.Solution
2.2.3. End User
2.2.4.Region
3.Global Lung Preservation Systems Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Lung Preservation Systems Market Analysis, 2020-2024 and Forecast 2025-2031
4.1.  Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Lung Preservation Systems Market  By Technique, 2020-2024 and Forecast 2025-2031 (Sales Value USD Million)
5.1. Hypothermic Perfusion Preservation (HPP)
5.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Static Cold Storage (SCS)
5.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Others
5.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
6.Global Lung Preservation Systems Market  By Solution, 2020-2024 and Forecast 2025-2031 (Sales Value USD Million)
6.1. Custodiol HTK - (Histidine-Tryptophan-Ketoglutarate) Solution
6.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Human Biosystem (HBS) Solution
6.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Renograf
6.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Viaspen
6.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Lifor
6.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
6.6. Perfadex
6.6.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.6.3. Market Opportunity Analysis 
6.7. Others
6.7.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
6.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.7.3. Market Opportunity Analysis 
7.Global Lung Preservation Systems Market  By  End User, 2020-2024 and Forecast 2025-2031 (Sales Value USD Million)
7.1. Hospitals
7.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Clinics
7.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Others
7.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
8.Global Lung Preservation Systems Market  By Region, 2020-2024 and Forecast 2025-2031 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9.North America Lung Preservation Systems Market ,2020-2024 and Forecast 2025-2031 (Sales Value USD Million)
9.1. Technique Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Hypothermic Perfusion Preservation (HPP)
9.1.2.Static Cold Storage (SCS)
9.1.3.Others
9.2.  Solution Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Custodiol HTK - (Histidine-Tryptophan-Ketoglutarate) Solution
9.2.2.Human Biosystem (HBS) Solution
9.2.3.Renograf
9.2.4.Viaspen
9.2.5.Lifor
9.2.6.Perfadex
9.2.7.Others
9.3.   End User Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Hospitals
9.3.2.Clinics
9.3.3.Others
9.4.  Country Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10.Europe Lung Preservation Systems Market ,2020-2024 and Forecast 2025-2031 (Sales Value USD Million)
10.1. Technique Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Hypothermic Perfusion Preservation (HPP)
10.1.2.Static Cold Storage (SCS)
10.1.3.Others
10.2.  Solution Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Custodiol HTK - (Histidine-Tryptophan-Ketoglutarate) Solution
10.2.2.Human Biosystem (HBS) Solution
10.2.3.Renograf
10.2.4.Viaspen
10.2.5.Lifor
10.2.6.Perfadex
10.2.7.Others
10.3.   End User Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Hospitals
10.3.2.Clinics
10.3.3.Others
10.4.  Country Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
10.4.6.Rest of EU
11.Asia Pacific (APAC) Lung Preservation Systems Market ,2020-2024 and Forecast 2025-2031 (Sales Value USD Million)
11.1. Technique Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Hypothermic Perfusion Preservation (HPP)
11.1.2.Static Cold Storage (SCS)
11.1.3.Others
11.2.  Solution Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Custodiol HTK - (Histidine-Tryptophan-Ketoglutarate) Solution
11.2.2.Human Biosystem (HBS) Solution
11.2.3.Renograf
11.2.4.Viaspen
11.2.5.Lifor
11.2.6.Perfadex
11.2.7.Others
11.3.   End User Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Hospitals
11.3.2.Clinics
11.3.3.Others
11.4.  Country Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12.Middle East and Africa (MEA) Lung Preservation Systems Market ,2020-2024 and Forecast 2025-2031 (Sales Value USD Million)
12.1. Technique Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Hypothermic Perfusion Preservation (HPP)
12.1.2.Static Cold Storage (SCS)
12.1.3.Others
12.2.  Solution Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Custodiol HTK - (Histidine-Tryptophan-Ketoglutarate) Solution
12.2.2.Human Biosystem (HBS) Solution
12.2.3.Renograf
12.2.4.Viaspen
12.2.5.Lifor
12.2.6.Perfadex
12.2.7.Others
12.3.   End User Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Hospitals
12.3.2.Clinics
12.3.3.Others
12.4.  Country Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13.Latin America Lung Preservation Systems Market ,2020-2024 and Forecast 2025-2031 (Sales Value USD Million)
13.1. Technique Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Hypothermic Perfusion Preservation (HPP)
13.1.2.Static Cold Storage (SCS)
13.1.3.Others
13.2.  Solution Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Custodiol HTK - (Histidine-Tryptophan-Ketoglutarate) Solution
13.2.2.Human Biosystem (HBS) Solution
13.2.3.Renograf
13.2.4.Viaspen
13.2.5.Lifor
13.2.6.Perfadex
13.2.7.Others
13.3.   End User Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Hospitals
13.3.2.Clinics
13.3.3.Others
13.4.  Country Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.Franz Kohler Chemie GmbH (Germany)
14.2.2.Organ Recovery Systems (U.S.)
14.2.3.Waters Medical Systems LLC (U.S.)
14.2.4.Essential Pharmaceuticals LLC (U.S.)
14.2.5.Xvivo Perfusion AB (Sweden)
14.2.6.BioLife Solutions, Inc. (U.S.)
14.2.7.Preservation Solutions, Inc. (U.S.)
14.2.8.Transmedics, Inc. (U.S.)
14.2.9.CryoLife, Inc. (U.S.)
15. Research Methodology 
16. Appendix and Abbreviations 

Key Market Players

  • Franz Kohler Chemie GmbH (Germany)
  • Organ Recovery Systems (U.S.)
  • Waters Medical Systems LLC (U.S.)
  • Essential Pharmaceuticals LLC (U.S.)
  • Xvivo Perfusion AB (Sweden)
  • BioLife Solutions, Inc. (U.S.)
  • Preservation Solutions, Inc. (U.S.)
  • Transmedics, Inc. (U.S.)
  • CryoLife, Inc. (U.S.)

Related Industry Reports

Heart Lung Machines Market

Global Lung Cancer Therapeutics Market